Ignite Creation Date:
2024-05-06 @ 10:25 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03250377
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-31
First Post:
2017-07-31
Brief Title:
A Study to Test the Safety Efficacy of Brivaracetam BRV Used as Adjunctive Treatment in Subjects 16 Years of Age With Partial Seizures With or Without Secondary Generalization
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
EP0085
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Biopharma SRL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None